Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancerDavid D.L. Bowtell, Frances R. Balkwill, Ronny Drapkin et al.|Nature reviews. Cancer|2015Cited by 1.4k
Premalignant SOX2 overexpression in the fallopian tubes of ovarian cancer patients: Discovery and validation studiesKarin Hellner, Ahmed A. Ahmed|EBioMedicine|2016Cited by 61
Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylationYiyan Zheng, Ahmed A. Ahmed|Nature Communications|2018Cited by 58
Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor-initiating cellsMara Artibani, Ahmed A. Ahmed, Kenta Masuda et al.|JCI Insight|2021Cited by 42
Loss of PFKFB4 induces cell death in mitotically arrested ovarian cancer cellsC R Taylor, Ahmed A. Ahmed|Oncotarget|2017Cited by 27